BackTcr2 Therapeutics Overview

Tcr2 Therapeutics Selling, General & Admin

Selling, General & Admin expenses for TCRR.

Quarterly SG&A Expenses

$8.20M
↑ 29.76% YoY

As of Mar 31, 2023

Annual SG&A Expenses (TTM)

$26.32M
↑ 13.67% YoY

Trailing 12 months ending Mar 31, 2023

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin